Abstract
Method Clinical parameters, activation of blood granulocytes and sputum phenotypes were assessed in 115 adult asthma patients (NCT01611012). Blood granulocytes were stained with antibodies against the active FcgRII receptor (CD32, clones A17/A27) and a-chain of MAC-1 (CD11b) in the presence or absence of fMLF, and analysed by flow cytometry. NLPCA was used to reduce dimensions in a combined cellular and clinical dataset, followed by discriminant analysis to generate a prediction model. Phenotypes identified by the model were cross-validated by inflammatory sputum phenotypes based on sputum induction (reference test). Results Peripheral blood eosinophil count, FeNO (Fraction of Exhaled Nitric Oxide), ACQ (Asthma Control Questionnaire), medication use, nasal polyposis, aspirin sensitivity and neutrophil/eosinophil responsiveness upon stimulation, are important parameters to differentiate between eosinophilic and non-eosinophilic phenotypes. The combinations of these parameters lead to an accurate prediction model for eosinophilic asthma with 90.5% sensitivity and 91.5% specificity.
Highlights
The clinical identification of inflammatory asthma phenotypes currently requires sputum analysis
Phenotyping asthma using an unsupervised prediction model based on blood granulocyte responsiveness
Clinical parameters, activation of blood granulocytes and sputum phenotypes were assessed in 115 adult asthma patients (NCT01611012)
Summary
The clinical identification of inflammatory asthma phenotypes currently requires sputum analysis. Sputum analysis has proven its value in diagnosis and disease monitoring. Technical limitations hamper its implementation in daily clinical practice. There is a strong need for fast, non-invasive and accurate diagnostic methods to phenotype and monitor asthma
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
